当前位置：公众访问 >页面
简体中文 / English
1.Screening
1.1.Management for Progress
1.1.1.1.1.1、Character of name

XDW

1.1.1.1.1.2、test number

41

1.1.1.1.1.3、Entering time

2019/10/18 (YYYY/MM/DD)

1.2.Inclusion Criteria

aspirin related small intestinal mucosal injury
/
agree with the research plan
/
sign the informed consent
1.3.Exclusion Criteria

contradications of MCCE
/
GI tract obstruction,or pregnant woman,or abdominal operation history, or can not undertake abdominal operation
/
taking drugs that influencing the test during the past one month
/
taking other antiplatelet or anticoagulant drugs
/
GI tumor or IBD diagnosed by MCCE
/
allergy to aspirin, lactobacillus, PEG,or high polymer material
2.Baseline
2.1.Management of the progress
2.2.General information
2.2.2.2.2.1、Basic information

2.2.2.2.2.2、Past history

冠心病、PCI术后4年

2.2.2.2.2.3、GSRS

4

2.3.First result of MCCE
2.2.3.2.3.1、Gastric injury Lanza score

0

2.2.3.2.3.2、Time of gastric examination

16 min

2.2.3.2.3.3、Other result of stomach

无

2.2.3.2.3.4、Small intestine injury score

1

2.2.3.2.3.5、Time of small intestine examination

120 min

2.2.3.2.3.6、Other result of small intestine

无

2.2.3.2.3.7、Whether or not to complete the smll intestine test

yes
2.2.3.2.3.8、Time of passing out the capsule

9 hour

2.2.3.2.3.9、Side effect of bowel preparation

无

2.2.3.2.3.10、Side effect of MCCE

无

2.4.Result of blood tests
2.2.4.2.4.1、Inflammatory cytokines

2.2.4.2.4.2、Others

2.5.Result of stool microbiota test
2.2.5.2.5.1、Phylum level

Actinobacteria 2.12 Ascomycota 0 Bacteroidetes 35.54 Euryarchaeota 0 Firmicutes 60.51 Fusobacteria 0 Proteobacteria 1.83 Synergistetes 0 Verrucomicrobia 0 Viruses_noname 0 others 0

2.2.5.2.5.2、Class level

Actinobacteria 2.1 Bacilli 6.18 Bacteroidia 31.43 Betaproteobacteria 0.32 Clostridia 57 Deltaproteobacteria 0.12 Erysipelotrichia 0 Gammaproteobacteria 1.63 Negativicutes 1.22 Verrucomicrobiae 0 others 0

2.2.5.2.5.3、Order level

Bacteroidales 30.62 Bifidobacteriales 0.7 Burkholderiales 0.4 Clostridiales 60.41 Coriobacteriales 0.41 Desulfovibrionales 0.1 Enterobacteriales 0.61 Lactobacillales 4.46 Selenomonadales 1.19 Verrucomicrobiales 0 others 1.09

2.2.5.2.5.4、Family level

Bacteroidaceae 34.83 Bifidobacteriaceae 0.59 Enterobacteriaceae 0.52 Eubacteriaceae 9.47 Lachnospiraceae 11.33 Porphyromonadaceae 0.54 Prevotellaceae 0 Rikenellaceae 0.41 Ruminococcaceae 34 Veillonellaceae 1.18 others 7.13

2.2.5.2.5.5、Genus level

Alistipes 0.42 Bacteroides 35.17 Bifidobacterium 0.71 Escherichia 0.13 Eubacterium 10.64 Faecalibacterium 20.28 Parabacteroides 0.75 Prevotella 0 Roseburia 10.45 Subdoligranulum 7.6 others 13.85

2.2.5.2.5.6、Specie level

Bacteroides_coprocola 0 Bacteroides_dorei 0 Bacteroides_ovatus 0.33 Bacteroides_plebeius 0 Bacteroides_stercoris 10.65 Bacteroides_vulgatus 8.2 Escherichia_coli 0.12 Eubacterium_rectale 9.9 Faecalibacterium_prausnitzii 20.95 Prevotella_copri 0 others 49.87

2.2.5.2.5.7、Functional gene

2.2.5.2.5.8、Functional pathway

2.2.5.2.5.9、Data of stool microbiata

2.6.Others

3.In the process of the treatment
3.1.Whether or not to enter the test and group

Blank control group
3.2.Primary symptom

3.3.Using other drugs

3.4.Side effect

无

3.5.Others

4.At the end of the treatment
4.1.Whether or not to exit

Complete the research
4.2.GSRS after treatmrnt

4.3.Sceond result of MCCE
4.4.3.4.3.1、Gastric injury Lanza score

1

4.4.3.4.3.2、Time of gastric examination

17 min

4.4.3.4.3.3、Other result of stomach

无

4.4.3.4.3.4、Small intestine injury score

3

4.4.3.4.3.5、Time of small intestine examination

240 min

4.4.3.4.3.6、Other result of small intestine

空肠多发黄色瘤

4.4.3.4.3.7、Whether or not to complete the smll intestine test

yes
4.4.3.4.3.8、Time of passing out the capsule

hour

4.4.3.4.3.9、Side effect of bowel preparation
4.4.3.4.3.10、Side effect of MCCE

无

4.4.Result of blood tests after treatment
4.4.4.4.4.1、Inflammatory cytokines

4.4.4.4.4.2、Others

4.5.Result of stool microbiota test after treatment
4.4.5.4.5.1、Phylum level

Actinobacteria 3.04 Ascomycota 0 Bacteroidetes 47.72 Euryarchaeota 0 Firmicutes 47.02 Fusobacteria 0.01 Proteobacteria 2.22 Synergistetes 0 Verrucomicrobia 0 Viruses_noname 0 others 0

4.4.5.4.5.2、Class level

Actinobacteria 3.06 Bacilli 2.69 Bacteroidia 43.13 Betaproteobacteria 0.45 Clostridia 46.45 Deltaproteobacteria 0.61 Erysipelotrichia 0.02 Gammaproteobacteria 1.57 Negativicutes 2.01 Verrucomicrobiae 0 others 0.01

4.4.5.4.5.3、Order level

Bacteroidales 42.22 Bifidobacteriales 0.85 Burkholderiales 0.57 Clostridiales 49.47 Coriobacteriales 0.95 Desulfovibrionales 0.49 Enterobacteriales 0.2 Lactobacillales 1.94 Selenomonadales 1.97 Verrucomicrobiales 0 others 1.33

4.4.5.4.5.4、Family level

Bacteroidaceae 43.96 Bifidobacteriaceae 0.71 Enterobacteriaceae 0.17 Eubacteriaceae 7.29 Lachnospiraceae 15.31 Porphyromonadaceae 0.8 Prevotellaceae 0 Rikenellaceae 2.66 Ruminococcaceae 22.68 Veillonellaceae 1.93 others 4.5

4.4.5.4.5.5、Genus level

Alistipes 2.7 Bacteroides 44.53 Bifidobacterium 0.85 Escherichia 0.06 Eubacterium 8.22 Faecalibacterium 12.93 Parabacteroides 1.12 Prevotella 0 Roseburia 6.18 Subdoligranulum 3.5 others 19.93

4.4.5.4.5.6、Specie level

Bacteroides_coprocola 0 Bacteroides_dorei 0.01 Bacteroides_ovatus 0.9 Bacteroides_plebeius 0 Bacteroides_stercoris 13.8 Bacteroides_vulgatus 10.18 Escherichia_coli 0.06 Eubacterium_rectale 5.07 Faecalibacterium_prausnitzii 13.69 Prevotella_copri 0 others 56.29

4.4.5.4.5.7、Functional gene

4.4.5.4.5.8、Functional pathway

4.4.5.4.5.9、Data of stool microbiata

4.6.Others after treatment

5.Logging data
5.1.Keyboarder

孙亚梅

5.2.Time of logging

2020/07/28 (YYYY/MM/DD)

6.Speciman management system
7.Data management system
8.ADR/ADE management system
9.Madicine management system
10.Research team
10.1.Researchers
11.Design, Methods
11.1.Calculation of sample size

提示：推荐使用chrome浏览器 并且在宽屏显示分辨率下使用系统。

Copyright(c) (2010-2013) .All rights reserved.临床试验公共管理平台 版权所有